Caplight Directory>Investors>Dexcom Ventures>Dexcom-ventures


Dexcom Ventures

Dexcom Ventures

San Diego, Californiadexcomventures.com

Overview

Dexcom Ventures is the corporate venture capital arm of Dexcom, launched in 2021. It focuses on investment opportunities in sensing technology, data analytics, remote patient monitoring, and population health, aiming to advance better outcomes in healthcare . The fund supports independent initiatives in glucose sensing technologies and adjacent fields of metabolic monitoring . Dexcom Ventures seeks to drive the next wave of health innovations via a world-class venture capital platform .

Year Founded

2021

Portfolio Companies

7

Investments

CompanyDateStageLead
SignosOct 2023Series BCo-investor
MedCryptJan 2023Series B ExtensionLead
NutromicsSep 2022SeedLead
Epitel, Inc.Feb 2022Series ACo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSan Diego, California
Year Founded2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.